Journal of Neuroscience, Vol 12, 3010-3024, Copyright © 1992 by Society for Neuroscience
Identification and developmental expression of a novel low molecular weight neuronal intermediate filament protein expressed in Xenopus laevis
LR Charnas, BG Szaro and H Gainer
Unit on Neurogenetics, NICHD, National Institutes of Health, Bethesda, Maryland 20892.
Xenopus laevis is a valuable model system for the study of vertebrate
neuroembryogenesis. However, very few well-characterized nervous system-
specific molecular markers are available for studies in this organism. We
screened a X. laevis adult brain cDNA library using a cDNA probe for mouse
low molecular weight neurofilament protein (NF-L) in order to identify
neuron-specific intermediate filament proteins. Clones for two distinct
neuron-specific intermediate filament proteins were isolated and sequenced.
One of these encoded for a Xenopus NF-L (XNF-L) and the other for a novel
neuron-specific Xenopus intermediate filament protein (XNIF) that was
present earlier and more abundantly than XNF-L during development. XNIF
contained a central rod domain with multiple sequence features
characteristic of IF proteins. The XNF-L was very similar to mouse NF-L,
with a 77% sequence identity in the rod domain and the presence of a
polyglutamic acid region in the tail domain, characteristic of type IV
neurofilament proteins. In contrast, XNIF showed only 60% identity to mouse
NF-L in the rod domain and lacked the glutamic acid-rich sequence in the
tail domain. XNIF also had a very low (approximately 38%) sequence identity
in the head and tail domains as compared to NF-L and other neurofilament
proteins (45% identity to the head domain of alpha-internexin). In the
adult frog, XNIF mRNA is detected by Northern blots only within the nervous
system and by in situ hybridization histochemistry exclusively in neurons,
particularly in the medullary reticular system and spinal cord. Antisera
raised against the unique tail region of XNIF detected a single distinct 60
kDa band in Western blots of nervous system cytoskeletal preparations, and
this XNIF immunoreactivity was concentrated in axons in the PNS and in
small perikarya in the dorsal root ganglion. In contrast, NF-L
immunoreactivity was principally in the large perikarya in the dorsal root
ganglion. In development, XNIF mRNA appears more abundant than XNF- L mRNA
in all premetamorphic stages examined. XNIF mRNA is first detectable at
stage 24 (26 hr), whereas stable expression of XNF-L is at stage 35/36 (50
hr). XNIF immunoreactivity is detectable within the cement gland, within
many neuronal cell bodies and axon tracts within the developing nervous
system, and within all cellular layers of the developing retina. The
availability of these two distinct neuron- specific intermediate filament
proteins, with different temporal and spatial expression patterns, should
provide new markers as well as targets for functional perturbation in the
developing X. laevis nervous system.